Igc Pharma Inc Asset Turnover Ratio (IGC), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Igc Pharma Inc   (NYSEAMER: IGC)
 

Igc Pharma Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2026, Igc Pharma Inc 's asset turnover ratio sequentially decreased to 0.11 in the second quarter (Jun 30 2026), this is lower than usual.

Within sector 152 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from to 3023.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IGC Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter		 (Mar 31 2025)
IV. Quarter
Y / Y Asset Change 42 % 5.01 % -28.23 % -6.04 % -25.02 %
Y / Y Revenue Change -19.7 % 23.35 % -53.64 % 20.59 % 11.86 %
Asset Turnover Ratio (TTM) 0.11 0.13 0.13 0.14 0.13
IGC's Total Ranking # 3023 # # 3197 # 3157 # 3271
Seq. Asset Change 22.8 % 5.01 % -10.22 % 22.66 % -9.19 %
Seq. Revenue Change -16.4 % 65.97 % -41.77 % -0.61 % 28.4 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 153
Healthcare Sector # 462
Overall Market # 3023

Asset Turnover Ratio Statistics
High Average Low
0.45 0.16 0.01
(Sep 30 2015)   (Sep 30 2021)




IGC Company Profile • Back to IGC Efficiency Comparisons • Compare IGC Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Repligen Corp  0.27 $ 785.101  Millions$ 2,938.591  Millions
Hcw Biologics Inc   0.26 $ 6.843  Millions$ 26.019  Millions
Bio rad Laboratories Inc   0.26 $ 2,589.000  Millions$ 10,078.725  Millions
Plus Therapeutics Inc   0.24 $ 4.203  Millions$ 17.235  Millions
Elutia Inc   0.24 $ 11.353  Millions$ 47.654  Millions
Retractable Technologies Inc  0.24 $ 33.488  Millions$ 142.089  Millions
Bio Green Med Solution Inc   0.23 $ 1.861  Millions$ 7.940  Millions
Petvivo Holdings Inc   0.23 $ 1.182  Millions$ 5.211  Millions
Biocorrx Inc   0.23 $ 0.787  Millions$ 3.478  Millions
Cannapharmarx Inc   0.21 $ 1.699  Millions$ 8.027  Millions
Ideaya Biosciences Inc   0.20 $ 234.127  Millions$ 1,158.627  Millions
Safe Pro Group Inc   0.20 $ 2.881  Millions$ 14.769  Millions
60 Degrees Pharmaceuticals Inc   0.19 $ 1.111  Millions$ 5.775  Millions
Moderna Inc   0.19 $ 2,228.000  Millions$ 11,730.500  Millions
Nrx Pharmaceuticals Inc   0.18 $ 3.394  Millions$ 18.504  Millions
Bioadaptives Inc   0.18 $ 0.026  Millions$ 0.141  Millions
Ligand Pharmaceuticals Incorporated  0.17 $ 290.542  Millions$ 1,688.847  Millions
Septerna Inc   0.17 $ 98.882  Millions$ 584.816  Millions
Inspiremd Inc   0.17 $ 10.502  Millions$ 62.247  Millions
Femasys Inc   0.14 $ 2.299  Millions$ 16.450  Millions
Igc Pharma Inc   0.12 $ 1.101  Millions$ 9.293  Millions
China Pharma Holdings Inc  0.11 $ 3.914  Millions$ 34.164  Millions
Pmgc Holdings Inc   0.11 $ 2.579  Millions$ 22.601  Millions
Tonix Pharmaceuticals Holding Corp   0.11 $ 29.102  Millions$ 260.403  Millions
Beam Therapeutics Inc   0.11 $ 156.035  Millions$ 1,414.853  Millions
Scilex Holding Company  0.11 $ 31.608  Millions$ 297.014  Millions
Nektar Therapeutics  0.09 $ 54.589  Millions$ 610.038  Millions
Lipocine Inc   0.08 $ 1.569  Millions$ 20.568  Millions
Catheter Precision Inc   0.07 $ 1.915  Millions$ 28.322  Millions
Metagenomi Therapeutics Inc   0.06 $ 13.561  Millions$ 209.924  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.